Thus, GRPR- and VPAC1R-bispecific radiotracers should be able to increase the specificity and sensitivity of prostate carcinoma imaging as well as that of other malignancies expressing these receptor types such as breast cancer. This evidence concerns the gene VIPR1 and breast carcinoma.